CCS
CDLX icon

Concentric Capital Strategies’s Cardlytics CDLX Stock Holding History

Concentric Capital Strategies’s Portfolio CDLX Stock Details CDLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-15,280
Closed -$489K – 279
2024
Q3 		$489K Buy
15,280
+190
+1% +$10.5K 0.02% 257
2024
Q2 		$1.24M Buy
+15,090
New +$1.63M 0.06% 238

Other funds holding CDLX

CIP
CAS Investment Partners Westport, Connecticut $1.75B AUM 41.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
KGAMU
KPS Global Asset Management (UK) London, United Kingdom $620M AUM 14.15% 1-Year Est. Return
WPM
Worldly Partners Management Needham, Massachusetts $118M AUM 19.19% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Concentric Capital Strategies's CDLX Position: Q3 2024 in Review

Concentric Capital Strategies sold out of Cardlytics (CDLX) in Q3 2024, closing a stake of 11,860 shares — an estimated $658K sold.

Concentric Capital Strategies first reported a position in CDLX in Q1 2024 and held it in 2 quarters. The position peaked at $1.54M in Q1 2024. 111 funds tracked by Wall St. Rank hold CDLX as of Q3 2024.

  • Concentric Capital Strategies reported no remaining Cardlytics position as of Q3 2024 after selling out during the quarter.
  • Concentric Capital Strategies sold 11,860 Cardlytics shares in Q3 2024, an estimated $658K.
  • Concentric Capital Strategies first reported a position in Cardlytics in Q1 2024 and held it in 2 quarters.
  • Concentric Capital Strategies's Cardlytics position peaked at $1.54M in Q1 2024.
  • 111 funds tracked by Wall St. Rank held Cardlytics as of Q3 2024.

Based on Concentric Capital Strategies's 13F filing for Q3 2024, filed 14 Nov 2024.